Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy
- PMID: 19903143
- DOI: 10.2174/092986709789878265
Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy
Abstract
Chronic and acute overproduction of reactive oxygen species (ROS) under pathophysiologic conditions forms an integral part of the development of cardiovascular diseases (CVD), and in particular atherosclerosis. These ROS are released from different sources, such as xanthine oxidase, lipoxygenase, nicotinamide adenine dinucleotide phosphate oxidase, the uncoupling of nitric oxide synthase and, in particular, mitochondria. Endothelial dysfunction, characterized by a loss of nitric oxide (NO) bioactivity, occurs early on in the development of atherosclerosis, and determines future vascular complications. Although the molecular mechanisms responsible for mitochondria-mediated disease processes are not clear, oxidative stress seems to play an important role. In general, ROS are essential to cell function, but adequate levels of antioxidant defenses are required in order to avoid the harmful effects of excessive ROS production. Mitochondrial oxidative stress damage and dysfunction contribute to a number of cell pathologies that manifest themselves through a range of conditions. This review considers the process of atherosclerosis from a mitochondrial perspective, and assesses strategies for the targeted delivery of antioxidants to mitochondria that are currently under development. We will provide a summary of the following areas: the cellular metabolism of reactive oxygen species (ROS) and its role in pathophysiological processes such as atherosclerosis; currently available antioxidants and possible reasons for their efficacy and inefficacy in ameliorating oxidative stress-mediated diseases; and recent developments in mitochondrially-targeted antioxidants that concentrate on the matrix-facing surface of the inner mitochondrial membrane in order to protect against mitochondrial oxidative damage, and their therapeutic potential as a treatment for atherosclerosis.
Similar articles
-
Mitochondrial dysfunction and antioxidant therapy in sepsis.Infect Disord Drug Targets. 2012 Apr;12(2):161-78. doi: 10.2174/187152612800100189. Infect Disord Drug Targets. 2012. PMID: 22420514 Review.
-
Mitochondria-targeted antioxidant peptides.Curr Pharm Des. 2010;16(28):3124-31. doi: 10.2174/138161210793292519. Curr Pharm Des. 2010. PMID: 20687871 Review.
-
Oxidative stress, endothelial dysfunction and atherosclerosis.Curr Pharm Des. 2009;15(26):2988-3002. doi: 10.2174/138161209789058093. Curr Pharm Des. 2009. PMID: 19754375 Review.
-
Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants.Infect Disord Drug Targets. 2009 Aug;9(4):376-89. doi: 10.2174/187152609788922519. Infect Disord Drug Targets. 2009. PMID: 19689380 Review.
-
Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases.Curr Pharm Des. 2007;13(8):845-63. doi: 10.2174/138161207780363077. Curr Pharm Des. 2007. PMID: 17430185 Review.
Cited by
-
Single-nucleus RNA sequencing reveals that macrophages and smooth muscle cells promote carotid atherosclerosis progression through mitochondrial autophagy.Medicine (Baltimore). 2024 Feb 16;103(7):e37171. doi: 10.1097/MD.0000000000037171. Medicine (Baltimore). 2024. PMID: 38363908 Free PMC article.
-
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases.Int J Mol Sci. 2023 Jan 12;24(2):1482. doi: 10.3390/ijms24021482. Int J Mol Sci. 2023. PMID: 36674998 Free PMC article. Review.
-
Impairment of endothelial function in Parkinson's disease.BMC Res Notes. 2022 Sep 5;15(1):284. doi: 10.1186/s13104-022-06176-z. BMC Res Notes. 2022. PMID: 36064624 Free PMC article.
-
Mitochondrial DNA Depletion Syndrome and Its Associated Cardiac Disease.Front Cardiovasc Med. 2022 Feb 14;8:808115. doi: 10.3389/fcvm.2021.808115. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35237671 Free PMC article. Review.
-
Non-Destructive Monitoring via Electrochemical NADH Detection in Murine Cells.Biosensors (Basel). 2022 Feb 10;12(2):107. doi: 10.3390/bios12020107. Biosensors (Basel). 2022. PMID: 35200367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical